|Bid||71.66 x 21400|
|Ask||71.69 x 12000|
|Day's Range||71.04 - 72.05|
|52 Week Range||49.25 - 74.99|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||123.57|
|Earnings Date||Aug 15, 2023|
|Forward Dividend & Yield||0.34 (0.47%)|
|Ex-Dividend Date||Sep 06, 2023|
|1y Target Est||70.31|
Subscribe to Yahoo Finance Plus to view Fair Value for PME.AX
Key Insights Significant insider control over Pro Medicus implies vested interests in company growth The top 2...
Pro Medicus ( ASX:PME ) Full Year 2023 Results Key Financial Results Revenue: AU$127.3m (up 35% from FY 2022). Net...
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the Visage® 7 Enterprise Imaging Platform ("Visage 7") has been ranked the #1 Universal Viewer (Imaging) in the 2023 Best in KLAS ® Software & Services Report by KLAS Research ("KLAS"). Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform, delivered entirely from the cloud or